The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The Europe dental implants market is expected to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Dental implants refer to surgical fixtures placed into the jawbone that enable dentists to mount replacement teeth or a bridge onto that area. They are connected with the gum tissues and underlying bone in the mouth. Today, dental implants are considered the standard care for prosthetic replacement of missing teeth in dentistry. People who lose a tooth or teeth due to periodontal disease, an injury, or some other reason opt for dental implant treatment as it provides a more secure and natural feel than conventional dentures.
The Europe dental implants market is primarily driven by the increasing elderly population in the region. Besides this, the rising awareness among individuals regarding dental health has also encouraged them to opt for dental implant treatments. Apart from this, countries, such as Germany, have advanced healthcare systems with a wide variety of dental facilities. The easy access to healthcare and treatment facilities is also providing a positive impact on the market growth. Moreover, the leading dental implant manufacturers in Europe are introducing new software that provides dentists with a versatile tool for supporting treatment planning and diagnostics.
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe dental implants market, along with forecasts at the regional and country level from 2021-2026. Our report has categorized the market based on material, product and end use.
Breakup by Material:
Breakup by Product:
Breakup by End Use:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis||2020|
|Segment Coverage||Material, Product, End Use, Country|
|Countries Covered||Germany, France, United Kingdom, Italy, Spain, Others|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License $ 2499
Five User License $ 2999
Corporate License $ 3999
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Swine Healthcare Market by Product (Diagnostic Tests, Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), Route of Administration (Injectable, Oral), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy), and Region 2023-2028
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2023-2028
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Gastric Cancer Drugs Market by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at